Skip to main content

Table 2 General characteristics of study patients

From: The effects of saffron supplementation on inflammation and hematological parameters in patients with sepsis: a randomized controlled trial

Variables

Saffron group

(N:45)

Placebo group

(N:45)

P-value*

Age, years

54.33 ± 2.2

54.17 ± 2.48

0.96

Female, n (%)

17 (37.8%)

18 (40%)

0.82

Weight (Kg)

76.80 ± 1.33

73.56 ± 1.35

0.09

Calf circumference (cm)

33.37 ± 0.49

32.12 ± 0.0.47

0.07

MAC (cm)

29.29 ± 0.90

27.31 ± 0.44

0.05

Reason for ICU admission

  

0.23

Medical

8 (17.8%)

8 (17.8%)

Trauma

32 (71.7%)

26 (57.8%)

Surgical

5 (11.1%)

11 (24.4%)

Energy requirement (Cal)

18,028 ± 20.55

1800.3526 ± 27.18

0.40

Energy intake (Cal)

1807.84 ± 17.48

1785.98 ± 165.78

0.47

Source of sepsis

  

0.41

Pulmonary infection

35 (77.8%)

28 (62.2%)

Abdominal infection

3 (6.7%)

5 (11.1)

CSF infection

1 (2.2%)

3 (6.7%)

Bacteremia

6 (13.3%)

9 (20%)

MAP (mmHg)

92.86 ± 1.87

89.68 ± 1.72

0.21

Current medication

   

NSAID

40 (88.9%)

37 (82.2%)

0.36

Insulin

4 (8.9%)

6 (13.3%)

0.50

PPI

40 (88.9%)

42 (93.3%)

0.45

Anticoagulant

42 (93.3%)

38 (84.4%)

0.18

Current supplement

   

Zinc

34 (75.6%)

37 (82.2%)

0.43

Vitamin C

6 (13.3%)

3 (6.7%)

0.48

Vitamin B1

27 (60%)

25 (55.6%)

0.67

Vitamin D

32 (71.1%)

35 (77.8%)

0.46

Magnesium

6 (13.3%)

12 (26.7%)

0.11

Vitamin B-complex

2 (4.4%)

4 (8.9%)

0.67

  1. Abbreviations: EXP; Expire, MAC; Mid-arm circumference, MAP; Mean arterial pressure, NSAID; Nonsteroidal anti-inflammatory drugs, PPI; Proton pump inhibitors
  2. Data are shown as means ± standard error or frequencies (percentage)
  3. P-values were obtained from the Chi-Square test or independent sample t-test*